1. Home
  2. IMRN vs MTEK Comparison

IMRN vs MTEK Comparison

Compare IMRN & MTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • MTEK
  • Stock Information
  • Founded
  • IMRN 1994
  • MTEK 2008
  • Country
  • IMRN Australia
  • MTEK Israel
  • Employees
  • IMRN N/A
  • MTEK N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • MTEK
  • Sector
  • IMRN Health Care
  • MTEK
  • Exchange
  • IMRN Nasdaq
  • MTEK Nasdaq
  • Market Cap
  • IMRN 14.4M
  • MTEK 15.1M
  • IPO Year
  • IMRN N/A
  • MTEK 2022
  • Fundamental
  • Price
  • IMRN $2.10
  • MTEK $1.69
  • Analyst Decision
  • IMRN
  • MTEK
  • Analyst Count
  • IMRN 0
  • MTEK 0
  • Target Price
  • IMRN N/A
  • MTEK N/A
  • AVG Volume (30 Days)
  • IMRN 96.3K
  • MTEK 95.0K
  • Earning Date
  • IMRN 08-29-2025
  • MTEK 09-26-2025
  • Dividend Yield
  • IMRN N/A
  • MTEK N/A
  • EPS Growth
  • IMRN N/A
  • MTEK N/A
  • EPS
  • IMRN N/A
  • MTEK N/A
  • Revenue
  • IMRN $4,777,422.00
  • MTEK $3,375,716.00
  • Revenue This Year
  • IMRN N/A
  • MTEK N/A
  • Revenue Next Year
  • IMRN N/A
  • MTEK N/A
  • P/E Ratio
  • IMRN N/A
  • MTEK N/A
  • Revenue Growth
  • IMRN 48.63
  • MTEK N/A
  • 52 Week Low
  • IMRN $1.50
  • MTEK $1.63
  • 52 Week High
  • IMRN $2.48
  • MTEK $6.47
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 50.56
  • MTEK 35.39
  • Support Level
  • IMRN $2.10
  • MTEK $1.63
  • Resistance Level
  • IMRN $2.24
  • MTEK $1.87
  • Average True Range (ATR)
  • IMRN 0.12
  • MTEK 0.13
  • MACD
  • IMRN -0.02
  • MTEK 0.00
  • Stochastic Oscillator
  • IMRN 32.50
  • MTEK 13.31

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

Share on Social Networks: